[Hematology].
D045930:Anabolic Agents / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000188:drug therapy; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use; D004912:Erythrocytes / Q000032:analysis; D005994:Glycerophosphates / Q000097:blood; D006402:Hematologic Diseases; D006467:Hemophilia A / Q000188:drug therapy; D006689:Hodgkin Disease / Q000145:classification / Q000628:therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D013156:Splenectomy
D045930:Anabolic Agents; D000933:Antifibrinolytic Agents; D005994:Glycerophosphates; D001215:Asparaginase